Caduet
From Self-sufficiency
 | This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (July 2008) |
| File:Amlodipine.png | |
| File:Lipitor.png | |
| Combination of | |
|---|---|
| Amlodipine | Calcium channel blocker |
| Atorvastatin | Statin |
| Clinical data | |
| Pregnancy category |
|
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| ATC code | C10BX03 (WHO) |
| PubChem | CID 9811759 |
| ChemSpider | 7987512 |
Caduet is a medication approved by the US FDA for the treatment of high cholesterol and high blood pressure. It is a fixed dose combination drug containing amlodipine, a calcium channel blocker (commonly sold as Norvasc), and atorvastatin (Lipitor). In many other countries, the combination is sold as Envacar. It is currently being marketed by the pharmaceutical company Pfizer.
References
- Lua error in package.lua at line 80: module 'Module:Citation/CS1/Suggestions' not found.
External links
- Manufacturer's site (caduet.com)
| 30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Articles needing additional references from July 2008
- Articles with invalid date parameter in template
- All articles needing additional references
- Pages with broken file links
- Drugs that are a combination of chemicals
- Infobox drug tracked parameters
- Infobox drug articles with contradicting parameter input
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- Statins
- Calcium channel blockers
- Pfizer
- Cardiovascular system drug stubs
- 2Fix
